Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options
Source: SeekingAlpha
2025-08-08 05:02:13 ET
Investment Thesis
Small biotech companies are usually “very high risk, but even higher reward”. In general, I look for companies that meet criteria such as:
- One-two approved products, and with positive cash-flow to be able to focus on pipeline (or a product in a very advanced phase with a clear path to positive cash flow).
- A blockbuster drug (close to $1B potential peak sales or more).
- Preferably with no debt.
- And, of course, undervalued according to my models.
Read the full article on Seeking Alpha
For further details see:
Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options
Eton Pharmaceutcials Inc.
NASDAQ: ETON
ETON Trading
-0.68% G/L:
$24.99 Last:
472,326 Volume:
$25 Open:
ETON Latest News
April 01, 2026 09:57:14 am
Eton Pharmaceutcials Inc. (NASDAQ: ETON) Sets New 52-Week High in Wednesday Session
March 19, 2026 04:05:00 pm
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
ETON Stock Data
$408,699,233
22,518,684
14.05%
24
N/A
Pharmaceuticals
Healthcare
US
Deer Park
